Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tight Glucose Control in Adult Critically Ill Patients (Leuven Algorithm)
2023-510358-17-00Phase 3Authorised
- Sponsor
- UZ Leuven
- Start
- Oct 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of regular human insulin in hyperglycemia and Stress Hyperglycemia (SH) (2 arms), sponsored by UZ Leuven. Planned start Oct 2024; status: authorised.
02
Drugs
regular human insulin
03
Conditions
hyperglycemiaStress Hyperglycemia (SH)
Beyond the preview
Go deeper on 2023-510358-17-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-510358-17-00.